462 filings
10-K
2023 FY
ELDN
Eledon Pharmaceuticals Inc
Annual report
28 Mar 24
4:30pm
8-K
ELDN
Eledon Pharmaceuticals Inc
28 Mar 24
Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Operating and Financial Results
4:01pm
SC 13G
Armistice Capital, LLC
14 Feb 24
Eledon Pharmaceuticals / ARMISTICE CAPITAL ownership change
3:35pm
SC 13G/A
Cormorant Asset Management, LP
14 Feb 24
Eledon Pharmaceuticals / Cormorant Asset Management ownership change
3:01pm
SC 13G/A
3nd5i65 iaq
14 Feb 24
Eledon Pharmaceuticals / BIOTECHNOLOGY VALUE FUND L P ownership change
10:06am
8-K
ilo6fmiq0jba3oeqqt
9 Nov 23
Eledon Pharmaceuticals Reports Third Quarter 2023 Operating and Financial Results
4:05pm
8-K
dyqcoyw1qkzx84ki6g
2 Nov 23
Eledon Reports Updated Data from Ongoing Phase 1b Trial Evaluating Tegoprubart for Prevention of Rejection in Kidney Transplantation
4:30pm
4
oru hb2xohyiq4753
3 Oct 23
Eledon Pharmaceuticals / James A. Jr. Robinson ownership change
4:19pm
4
w770lt3boy
3 Oct 23
Eledon Pharmaceuticals / Allan Kirk ownership change
4:17pm
3
xujt90v2v
2 Oct 23
Eledon Pharmaceuticals / James A. Jr. Robinson ownership change
5:51pm
3
nddwcyfx
2 Oct 23
Eledon Pharmaceuticals / Allan Kirk ownership change
5:08pm
8-K
rlt4m7v3s
2 Oct 23
Departure of Directors or Certain Officers
7:30am
8-K
fkgsb4b fa63
20 Sep 23
Departure of Directors or Certain Officers
7:09pm
8-K
y87hyx5
13 Sep 23
Departure of Directors or Certain Officers
4:42pm
S-8
ewasp20ujyf2g5nx
10 Aug 23
Registration of securities for employees
6:28pm
8-K
zcvkju0o5ehqhql
10 Aug 23
Eledon Pharmaceuticals Reports Second Quarter 2023 Operating and Financial Results
7:05am
8-K
67vodt
21 Jun 23
Departure of Directors or Certain Officers
7:51pm